Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/article/10.1186/s12916-014-0140-3/fulltext.html
Reference34 articles.
1. Chmielecki J, Meyerson M: DNA sequencing of cancer: what have we learned?. Annu Rev Med. 2014, 65: 63-79. 10.1146/annurev-med-060712-200152.
2. Garraway LA, Verweij J, Ballman KV: Precision oncology: an overview. J Clin Oncol. 2013, 31: 1803-1805. 10.1200/JCO.2013.49.4799.
3. Eroglu Z, Tagawa T, Somlo G: Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancer. Oncologist. 2014, 19: 135-150. 10.1634/theoncologist.2013-0283.
4. Gridelli C, Peters S, Sgambato A, Casaluce F, Adjei AA, Ciardiello F: ALK inhibitors in the treatment of advanced NSCLC. Cancer Treat Rev. 2014, 40: 300-306. 10.1016/j.ctrv.2013.07.002.
5. Jain N, O'Brien S: The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatment. Expert Rev Hematol. 2013, 6: 575-586. 10.1586/17474086.2013.835697.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of machine learning to classify cancers of unknown primary;MedComm – Oncology;2023-12
2. Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis;Frontiers in Oncology;2023-08-15
3. Economic evaluation of rare diseases and the diagnostic odyssey;Economic Evaluation in Genomic and Precision Medicine;2023
4. The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers;American Journal of Clinical Pathology;2021-03-17
5. RNA sequencing reveals the expression profiles of circRNA and identifies a four-circRNA signature acts as a prognostic marker in esophageal squamous cell carcinoma;Cancer Cell International;2021-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3